Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Resectable Adult Primary Liver Cancer”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Early research (Phase 1)Study completedNCT01008566
What this trial is testing

Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT01182272
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery

Who this might be right for
Liver Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 36
Testing effectiveness (Phase 2)WithdrawnNCT00020774
What this trial is testing

SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Ended earlyNCT00023946
What this trial is testing

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)WithdrawnNCT04965714
What this trial is testing

Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer

Who this might be right for
Resectable Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004108
What this trial is testing

DX-8951f in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)UnknownNCT00276705
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

Who this might be right for
Liver Cancer
Children's Cancer and Leukaemia Group 47
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Testing effectiveness (Phase 2)Study completedNCT01395030
What this trial is testing

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Who this might be right for
Adult Hepatocellular CarcinomaLocalized Resectable Adult Liver Carcinoma
Queen's Medical Center 64
Large-scale testing (Phase 3)Study completedNCT00363584
What this trial is testing

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University Hospital Southampton NHS Foundation Trust 360
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT01425879
What this trial is testing

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04196465
What this trial is testing

Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers

Who this might be right for
Subjects With Resectable and Localized Gastric CancerSubjects With Resectable Esophageal Cancer or Liver CancerSubjects With Resectable Liver Cancer
Asan Medical Center 48
Large-scale testing (Phase 3)WithdrawnNCT00238160
What this trial is testing

Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer

Who this might be right for
Localized Resectable Adult Primary Liver CancerStage III Childhood Liver Cancer
Kyoto University
Testing effectiveness (Phase 2)Study completedNCT03222076
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer

Who this might be right for
Hepatocellular CarcinomaResectable Hepatocellular Carcinoma
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT03734068
What this trial is testing

Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC

Who this might be right for
Hepatocellular Carcinoma
International Group of Endovascular Oncology 100
Load More Results